Applications of artificial intelligence (AI) in ovarian cancer, pancreatic cancer, and image biomarker discovery.

Journal: Cancer biomarkers : section A of Disease markers
Published Date: Jan 1, 2022

Abstract

BACKGROUND: Artificial intelligence (AI), including machine learning (ML) and deep learning, has the potential to revolutionize biomedical research. Defined as the ability to "mimic" human intelligence by machines executing trained algorithms, AI methods are deployed for biomarker discovery.

Authors

  • Dina Mikdadi
    Biomedical Data Science Lab, Deloitte Consulting LLP, Arlington, VA, USA.
  • Kyle A O'Connell
    Biomedical Data Science Lab, Deloitte Consulting LLP, Arlington, VA, USA.
  • Philip J Meacham
    Biomedical Data Science Lab, Deloitte Consulting LLP, Arlington, VA, USA.
  • Madeleine A Dugan
    Biomedical Data Science Lab, Deloitte Consulting LLP, Arlington, VA, USA.
  • Michael O Ojiere
    Biomedical Data Science Lab, Deloitte Consulting LLP, Arlington, VA, USA.
  • Thaddeus B Carlson
    Biomedical Data Science Lab, Deloitte Consulting LLP, Arlington, VA, USA.
  • Juergen A Klenk
    Biomedical Data Science Lab, Deloitte Consulting LLP, Arlington, VA, USA.

Keywords

External Resources

Popular Topics
Recent Journals